Paul Beswick, an officer at Marsh & McLennan Companies, Inc., has filed to sell 713 shares of the company following a restricted stock vesting. This transaction is significant as it highlights the ongoing management of equity holdings by executives in the insurance sector.

Marsh & McLennan Companies, Inc. is a leading global professional services firm specializing in insurance, risk management, and consulting. The company operates under the SIC classification for Insurance Agents, Brokers, and Services. Its recent filings include a Form 144, which was submitted on November 5, 2026, indicating a planned sale of common stock.

According to the filing, the sale of 713 shares has an aggregate market value of approximately $151,705.01, based on the current trading price on the New York Stock Exchange. The shares were acquired on February 28, 2026, as part of a restricted stock vesting transaction, which is a common form of compensation for executives.

This filing may affect stakeholders within Marsh & McLennan, including investors and other executives, as it reflects the company's internal equity management strategies. The insurance industry may also take note of such transactions, as they can indicate broader trends in executive compensation and stock management.

The filing does not specify any immediate next steps following this transaction.